OTUD6B
Deubiquitinase OTUD6B
Also known as: CGI-77, DUBA5, OTU6B_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q8N6M0
- Gene
- OTUD6B
- Ensembl
- ENSG00000155100
- Chromosome
- 8
- Canonical length
- 293 aa
- Protein class
- Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins
- Subcellular location
- Nucleoplasm,Golgi apparatus,Cytosol
OverviewNCBI Gene
This gene encodes a member of the ovarian tumor domain (OTU)-containing subfamily of deubiquitinating enzymes. Deubiquitinating enzymes are primarily involved in removing ubiquitin from proteins targeted for degradation. This protein may function as a negative regulator of the cell cycle in B cells. [provided by RefSeq, Nov 2013]
Canonical amino-acid sequenceUniProt
293 residues, UniProt reviewed canonical sequence.
>Q8N6M0|OTUD6B
1 MEAVLTEELD EEEQLLRRHR KEKKELQAKI QGMKNAVPKN DKKRRKQLTE DVAKLEKEME
61 QKHREELEQL KLTTKENKID SVAVNISNLV LENQPPRISK AQKRREKKAA LEKEREERIA
121 EAEIENLTGA RHMESEKLAQ ILAARQLEIK QIPSDGHCMY KAIEDQLKEK DCALTVVALR
181 SQTAEYMQSH VEDFLPFLTN PNTGDMYTPE EFQKYCEDIV NTAAWGGQLE LRALSHILQT
241 PIEIIQADSP PIIVGEEYSK KPLILVYMRH AYGLGEHYNS VTRLVNIVTE NCSLocalizationUniProt · AlphaFold · HPA
Whether an antibody against OTUD6B can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Unknown
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.39
- Highest tissue expression
- 9.6 nTPM
Expression across tissuesHPA
Tissue
- skeletal muscle: 9.6 nTPM
- cerebral cortex: 8.6 nTPM
- tongue: 8.6 nTPM
- spinal cord: 7.9 nTPM
- placenta: 7.5 nTPM
- lymph node: 6.9 nTPM
Single-cell type
- sertoli cells: 44 nCPM
- tuft cells: 35 nCPM
- microglia: 33 nCPM
- pituicytes/fscs: 33 nCPM
- basal keratinocytes: 32 nCPM
- cone photoreceptor cells: 29 nCPM
Immune cell
- plasmacytoid DC: 4 nTPM
- NK-cell: 3.4 nTPM
- intermediate monocyte: 2.7 nTPM
- myeloid DC: 2.6 nTPM
- naive CD4 T-cell: 2.1 nTPM
- non-classical monocyte: 2.1 nTPM
Brain region
- white matter: 11 nTPM
- spinal cord: 8.5 nTPM
- medulla oblongata: 8.4 nTPM
- midbrain: 8.3 nTPM
- hypothalamus: 8 nTPM
- basal ganglia: 7.9 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about OTUD6B.
Disease | AllUniProt
Conditions OTUD6B is implicated in, by any mechanism.
- Intellectual developmental disorder with dysmorphic facies, seizures, and distal limb anomalies (IDDFSDA) MIM:617452
Disease | GeneticClinVar
20 pathogenic / likely-pathogenic of 111 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Intellectual developmental disorder with dysmorphic facies, seizures, and distal limb anomalies
- Epilepsy
- Dysmorphic features
- Intellectual disability
- Inborn genetic diseases
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.32
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.3
- DepMap mean gene effect
- -0.03
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 14% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- cell population proliferation
- negative regulation of translation
- positive regulation of translation
- proteasome assembly
- protein deubiquitination
- proteolysis
Molecular functions
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of OTUD6B in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads OTUD6B as an antibody target. Whether an autoantibody or antibody against OTUD6B could matter depends on whether native OTUD6B is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
OTUD6B is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label OTUD6B as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...